BD Pen Needles and syringes are used to inject insulin. Always consult your Healthcare Professional regarding treatment of your diabetes. Always read the label and follow the directions for use.
-
ANZ
North America
South America
Europe
Middle East / Africa
Asia / Pacific
BD Micro fine Pen Needle Portfolio
Full Portfolio of pen needles to support your Patient's Needs
.png)
- Overview
false
| Overview |
| embecta offers a full portfolio of pen needles for a wide variety of patient needs |
| Full range of needle lengths |
| BD Micro-FineTM Pen Needles are available in 4mm, 5mm, 6mm, 8mm and 12.7mm needle lengthsBD Micro-FineTM Pen Needles are available in 4mm, 5mm, 6mm, 8mm and 12.7mm needle lengths |
| #1 selling brand globally |
| BD™ Pen Needles are used and trusted by more than 30 million people worldwide and #1 selling brand of pen needles globally.1BD™ Pen Needles are used and trusted by more than 30 million people worldwide and #1 selling brand of pen needles globally.1 |
| Compatibility |
| BD Micro-FineTM Pen Needles are compatible with widely used pen injection devices.2BD Micro-FineTM Pen Needles are compatible with widely used pen injection devices.2 |
| Quality |
| Our products are designed and manufactured to quality standards, rigorously tested to ensure that performance requirements are compliant with stringent ISO standards.* |
Single Use
| Recommend the use of a new pen needle every time your patients inject. Pen needles are recommended to be used only once and are no longer sterile after that. There is an association between needle reuse and injection pain or bleeding.3 |
| BD Safe-ClipTM Needle Clipping Device - SKU #328235 |
| Single Use |
| BD Micro-FineTM+ Pen Needles 6mm 31G - SKU #320737 BD Micro-FineTM+ Pen Needles 8mm 31G - SKU #320471 BD Micro-FineTM+ Pen Needles 12.7mm 29G - SKU #320473 |
*CPR-069: Process Validation Procedure, ISO 13485, ISO 14971.
1. Data on file.
2. BD Compatibility Confirmation for Pen Needles and Pen Injector Manufacturers. 149-OTH-0004-20, Rev S. February 2021.
3. Frid AH, et al. New Insulin Delivery Recommendations. Mayo Clinic Proceedings. 2016;91(9):1231–1255
false
embecta, formerly part of BD. BD is the manufacturer of the advertised products.